3 Reasons Why You Might Not Want to Buy Pfizer Stock

Pfizer (NYSE: PFE) delivered sizzling growth in the second quarter. Its COVID-19 vaccine continues to rake in billions of dollars. Several of the company's other products are generating strong sales growth. Pfizer's dividend is attractive. In this Motley Fool Live video recorded on Aug. 4, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about why investors might not want to buy Pfizer stock despite all of these tailwinds.

Continue reading

Source Fool.com